Enzo Biochem, Inc.
Head Quarters
527 Madison Avenue USWebsite
http://www.enzo.comIndustry
BiotechnologyEmployees
489Exchange
New York Stock Exchange, Inc.Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 4 |
| Gross Margin (%) | 0.45% |
| Net Margin (%) | -0.01% |
| Returns | Stock |
| Sales | $105.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$2.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 1.86 |
| EPS | $0.00 |